基于表型的药物诱导肝损伤的化学模型:从公共数据到专有数据
Mohammad Moein1, Markus Heinonen1, Natalie Mesens2
1Department of Computer Science, Aalto University, Konemiehentie 2, 02150 Espoo, Finland.
Chemical research in toxicology
|August 9, 2023
概括
本研究引入了一种使用临床前毒理学数据预测药物诱导肝损伤 (DILI) 的新方法. 增强的数据集可以提高机器学习模型对DILI预测的准确性.
科学领域:
- 毒理学 毒理学 毒理学
- 计算化学计算化学
- 机器学习 机器学习
背景情况:
- 药物诱导性肝损伤 (DILI) 是一个重要的安全问题,导致药物市场退出.
- 目前的DILI预测模型通常依赖于药物标签或病例报告中的有限的二进制注释.
- 机器学习的进步为使用化学结构改善in silico DILI预测提供了潜力.
研究的目的:
- 开发一个更具信息性的数据集,用于DILI预测,使用一种基于临床前毒理学研究的新型表型注释.
- 构建和评估用于DILI预测的机器学习模型,利用这种增强的数据集.
- 评估数据源差异对模型概括的影响.
主要方法:
- 从使用INHAND注释的体内临床前毒理学研究中提取了肝毒性信息.
- 创建了430种独特化合物的数据集,其中包括各种肝病理学发现.
- 在TG-GATE数据集上使用复合指纹开发和训练DILI预测模型.
- 使用约翰逊和约翰逊公司的外部测试套件验证模型.
主要成果:
- 证明成功地预测了TG-GATE化合物的DILI标签.
- 量化了数据集差异对模型概括性能的影响.
- 强调了基于表型的注释对DILI预测的有用性.
结论:
- 新的基于表型的注释为基于机器学习的DILI预测提供了更可靠的数据集.
- 机器学习模型可以使用化学结构和临床前数据有效预测DILI.
- 了解数据集差异对于DILI预测中的强大的模型概括至关重要.
相关概念视频
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
61
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
61
Pharmacokinetic Models: Comparison and Selection Criterion
104
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
104
Pharmacokinetic Models: Overview
786
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
786
Model Approaches for Pharmacokinetic Data: Physiological Models
75
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
75


